Last deal

$100M

Amount

Seed

Stage

25.09.2023

Date

1

all rounds

$100M

Total amount

General

About Company
Nvelop Therapeutics offers gene editing technology services for major diseases.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Nvelop

founded date

2022

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

Nvelop Therapeutics is a biotechnology company that specializes in providing gene editing technology services to address unmet needs in major diseases. Their expertise lies in utilizing advanced gene editing techniques to develop innovative solutions for treating and preventing these diseases. By leveraging their cutting-edge technology, Nvelop Therapeutics aims to make significant advancements in the field of biotechnology and contribute to improving global healthcare.
Contacts

Social url